Table 2.

Patients’ characteristics (validation cohort)

Variable	Validation cohort (N = 64 patients)
COO (NanoString)
ABC	N/A
GCB	N/A
UNC	N/A
MYC/BCL-2 DEXP mRNA
Yes	N/A
No	N/A
IPI, n (%)
Low (0-2)	45 (70)
High (3-5)	19 (30)
Sex, n (%)
Female	29 (45)
Male	35 (55)
Age, y, median (range)	61.6 (18.1-83.4)
Stage, n (%)
I	6 (9)
II	20 (31)
III	3 (5)
IV	35 (55)
Follow-up, mo, median (range)	50.26 (0.89-135.48)

N/A, not applicable.